The FDA's patient-focused drug development initiative

Clin Adv Hematol Oncol. 2021 Feb;19(2):70-72.

Authors

Paul G Kluetz¹, Vishal Bhatnagar¹

Affiliation

¹ Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD.

PMID: 33596186

No abstract available

Publication types

Interview

MeSH terms

Antineoplastic Agents / therapeutic use*
Clinical Trials as Topic / methods
Congresses as Topic
Drug Development / organization & administration*
Drug Industry
Health Policy
Humans
Intersectoral Collaboration
Medical Oncology
Neoplasms / drug therapy
Neoplasms / psychology
Patient Advocacy
Patient Preference
Patient-Centered Care / organization & administration*
United States
United States Food and Drug Administration* / organization & administration

Substances

Antineoplastic Agents